Dyspnea and Systemic sclerosis (scleroderma)

Summary:

Systemic sclerosis (scleroderma) is found among people with Dyspnea, especially for people who are female, 60+ old.

The study analyzes which people have Systemic sclerosis (scleroderma) with Dyspnea. It is created by eHealthMe based on reports of 11 people who have Dyspnea from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Dyspnea?

Dyspnea (difficult or laboured breathing) is found to be associated with 3,715 drugs and 6,067 conditions by eHealthMe. Check the latest studies of Dyspnea.

What is Systemic sclerosis (scleroderma)?

Systemic sclerosis (scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin) is found to be associated with 495 drugs and 857 conditions by eHealthMe. Check the latest studies of Systemic sclerosis (scleroderma).



On Jul, 17, 2026

11 people who have Dyspnea and Systemic Sclerosis (Scleroderma) are studied.

Would you have Systemic sclerosis (scleroderma) when you have Dyspnea?

Gender of people who have Dyspnea and experienced Systemic Sclerosis (Scleroderma) *:

  • female: 81.82 %
  • male: 18.18 %

Age of people who have Dyspnea and experienced Systemic Sclerosis (Scleroderma) *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 30 %
  • 60+: 70 %

Common co-existing conditions for these people *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 45.45%
  2. Pulmonary Hypertension (increase in blood pressure in the lung artery): 5 people, 45.45%
  3. Pain: 4 people, 36.36%
  4. Osteoporosis (bones weak and more likely to break): 4 people, 36.36%
  5. High Blood Cholesterol: 4 people, 36.36%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 36.36%
  7. Skin Ulcer: 2 people, 18.18%
  8. Neuropathy Peripheral (surface nerve damage): 2 people, 18.18%
  9. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 18.18%
  10. Inflammation: 2 people, 18.18%

Common drugs taken by these people *:

  1. Revatio: 5 people, 45.45%
  2. Zocor: 4 people, 36.36%
  3. Remodulin: 4 people, 36.36%
  4. Kenalog: 4 people, 36.36%
  5. Lasix: 4 people, 36.36%
  6. Deltasone: 4 people, 36.36%
  7. Zestril: 4 people, 36.36%
  8. Calcium: 4 people, 36.36%
  9. Plaquenil: 4 people, 36.36%
  10. Atrovent: 4 people, 36.36%

Common symptoms for these people *:

  1. Pulmonary Hypertension (increase in blood pressure in the lung artery): 4 people, 36.36%
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 36.36%
  3. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 36.36%
  4. Increased Upper Airway Secretion: 3 people, 27.27%
  5. Hypoaesthesia (reduced sense of touch or sensation): 3 people, 27.27%
  6. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 27.27%
  7. Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 27.27%
  8. Disease Progression: 2 people, 18.18%
  9. Fractured Sacrum: 2 people, 18.18%
  10. Fatigue (feeling of tiredness): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Systemic sclerosis (scleroderma)?

- Check whether Systemic sclerosis (scleroderma) is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Systemic sclerosis (scleroderma):

All the conditions that are associated with Systemic sclerosis (scleroderma):


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Systemic sclerosis (scleroderma) and Dyspnea, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: